- Home
- PMCB vs ADIL Comparison
PMCB vs ADIL Comparison
Compare PMCB & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- ADIL
- Stock Information
- Founded
- PMCB 1996
- ADIL 2010
- Country
- PMCB United States
- ADIL United States
- Employees
- PMCB N/A
- ADIL N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- PMCB Health Care
- ADIL Health Care
- Exchange
- PMCB Nasdaq
- ADIL Nasdaq
- Market Cap
- PMCB 5.8M
- ADIL 6.0M
- IPO Year
- PMCB N/A
- ADIL 2018
- Fundamental
- Price
- PMCB $0.90
- ADIL $0.39
- Analyst Decision
- PMCB
- ADIL Strong Buy
- Analyst Count
- PMCB 0
- ADIL 1
- Target Price
- PMCB N/A
- ADIL $8.00
- AVG Volume (30 Days)
- PMCB 38.8K
- ADIL 4.0M
- Earning Date
- PMCB 08-11-2025
- ADIL 08-13-2025
- Dividend Yield
- PMCB N/A
- ADIL N/A
- EPS Growth
- PMCB N/A
- ADIL N/A
- EPS
- PMCB 3.19
- ADIL N/A
- Revenue
- PMCB N/A
- ADIL N/A
- Revenue This Year
- PMCB N/A
- ADIL N/A
- Revenue Next Year
- PMCB N/A
- ADIL N/A
- P/E Ratio
- PMCB $0.28
- ADIL N/A
- Revenue Growth
- PMCB N/A
- ADIL N/A
- 52 Week Low
- PMCB $0.80
- ADIL $0.22
- 52 Week High
- PMCB $2.42
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- PMCB 41.85
- ADIL 45.40
- Support Level
- PMCB $0.84
- ADIL $0.38
- Resistance Level
- PMCB $0.95
- ADIL $0.42
- Average True Range (ATR)
- PMCB 0.07
- ADIL 0.06
- MACD
- PMCB -0.00
- ADIL -0.01
- Stochastic Oscillator
- PMCB 39.96
- ADIL 10.73
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.